Study of diluent volume for inhaled colistin
Part of Infections, Lungs & breathing clinical trials.
This trial tests how the amount of liquid mixed with colistin affects treatment when inhaled by patients on ventilators. The goal is to find the best way to give this antibiotic therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (ICU).
- You are over 18 and on a breathing machine due to sudden breathing failure.
- Your doctor has decided you need colistin inhaled into your lungs.
- You sign a consent form agreeing to be in the study.
- You do not have kidney failure that requires dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a nebulized (inhaled) antibiotic called colistin can prevent lung infections in children who have been on a breathing machine for more than 48 hours. If your child is eligible, the treatment may help reduce the risk of ventilator-associated pneumonia.
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
This trial tests if inhaling a medication called colistin can prevent ventilator-associated pneumonia (a lung infection) in patients who are on a breathing machine. It aims to reduce the risk for those at high risk of getting an infection from drug-resistant bacteria.
This study tests different ways of giving the antibiotic colistin to patients in the ICU with infections that are hard to treat. The goal is to find the best dosing schedule to help you fight the infection more effectively.
This trial tests if an inhaled antibiotic (amikacin) can treat an infection in the breathing tube (ventilator-associated tracheobronchitis) better than a placebo. You may qualify if you are on a ventilator and have this type of infection.
This trial tests a drug called Polymyxin E2 Methanesulfonate for a serious lung infection that patients can get in the hospital, caused by bacteria that don't respond to common antibiotics. It may be an option for people on ventilators or recently hospitalized with pneumonia that standard drugs can't treat.
Hear when a new Inhalation Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.